These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 805176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of the immune response in vitro and in vivo by splenocytes from tumor-bearing mice.
    Specter SC, Kamo I, Friedman H.
    Adv Exp Med Biol; 1976; 66():457-63. PubMed ID: 817575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
    DeLustro F, Argyris BF.
    J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F, Levy JG, Kilburn DG.
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
    Yonkosky D, Buffett RF, Bennett M.
    J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F, Levy JG, Kilburn DG.
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [Abstract] [Full Text] [Related]

  • 15. Tumor-induced immunosuppression.
    Friedman H, Specter S, Watanabe M, Pan SH.
    Am J Pathol; 1978 Nov; 93(2):499-514. PubMed ID: 102206
    [Abstract] [Full Text] [Related]

  • 16. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA.
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [Abstract] [Full Text] [Related]

  • 17. Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro.
    Wason WM, Fitch FW.
    J Immunol; 1973 May; 110(5):1427-9. PubMed ID: 4572635
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH, Hoover SK, Susskind BM, Barrett SK, Bear HD.
    Cancer Res; 1992 Mar 15; 52(6):1386-92. PubMed ID: 1531782
    [Abstract] [Full Text] [Related]

  • 20. Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.
    Douglas GN, Rubin AS.
    Immunology; 1977 May 15; 32(5):669-79. PubMed ID: 324897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.